Sign In
Buy MITO
$0.320
+0 (+0%)
At Close: Feb 14, 2023
Stealth BioTherapeutics (MITO): Over 25% Increase Pre-Market Explanation
08:36am, Tuesday, 18'th May 2021
The stock price of Stealth BioTherapeutics Corp (NASDAQ: MITO) increased by over 25% pre-market. This is why it happened.
Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights
07:30am, Tuesday, 18'th May 2021
BOSTON, May 18, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies
Stealth BioTherapeutics Stock Surges On $30M Funding To Advance Elamipretide Development
06:21am, Tuesday, 18'th May 2021
Stealth BioTherapeutics Corp (NASDAQ: MITO) has reached an agreement with Morningside Ventures for Morningside to provide $30 million in additional payments to the Company during 2021 under its ex
Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials
05:00pm, Monday, 17'th May 2021
BOSTON, May 17, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies
Stealth BioTherapeutics to Report First Quarter Financial Results on Tuesday, May 18, 2021
04:30pm, Tuesday, 11'th May 2021
BOSTON, May 11, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
Top Penny Stocks For Your Thursday Morning Watchlist
09:14am, Thursday, 06'th May 2021
Will these 3 penny stocks be on your Thursday morning watchlist? The post Top Penny Stocks For Your Thursday Morning Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
MITO Stock: 77.5% Increase (From $1.20 To $2.13 Increase) Pre-Market Explanation
06:24am, Thursday, 06'th May 2021
The stock price of Stealth BioTherapeutics Corp (NASDAQ: MITO) increased 77.5% (from $1.20 to $2.13) during pre-market trading. This is why it happened.
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting
04:30pm, Wednesday, 05'th May 2021
BOSTON, May 5, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies
BOSTON, April 28, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therap
Stealth BioTherapeutics CEO to Give Keynote Presentation at Mitochondria-Targeted Drug Development Summit
07:30am, Monday, 26'th Apr 2021
BOSTON, April 26, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapi
Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q4 2020 Results - Earnings Call Transcript
11:46am, Tuesday, 06'th Apr 2021
Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q4 2020 Results - Earnings Call Transcript
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
07:30am, Tuesday, 06'th Apr 2021
BOSTON, April 6, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapi
Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021
05:30pm, Wednesday, 31'st Mar 2021
BOSTON, March 31, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapie
Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome
08:00pm, Tuesday, 05'th Jan 2021
BOSTON, Jan. 5, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
BOSTON, Dec. 9, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
